PE Anti-CD105 antibody [MEM-229]
Be the first to review this product! Submit a review
|
(28 Publications)
Mouse Monoclonal CD105 antibody - conjugated to PE. Suitable for IHC-Fr and reacts with Pig samples. Cited in 28 publications. Immunogen corresponding to Recombinant Virus within Human ENG.
View Alternative Names
CD105, END, ENG, Endoglin
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - PE Anti-CD105 antibody [MEM-229] (AB53321)
ab53318 staining CD105 in infarcted porcine heart by Immunohistochemistry (Frozen sections). Cell nuclei were counterstained blue with DAPI.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Endoglin functions in the regulation of angiogenesis and vascular remodeling. It plays a significant role in mediating cellular responses to TGF-beta signaling influencing endothelial cell proliferation and migration. While not part of a larger structural complex endoglin interacts with receptors and signaling molecules important for vascular development and repair processes. This involvement aids in maintaining endothelial integrity and function under various physiological conditions.
Pathways
CD105 participates in the TGF-beta signaling and angiogenesis pathways. In these pathways it acts in conjunction with other proteins like TGF-beta receptors which play roles in cell differentiation proliferation and apoptosis. The interaction between CD105 and TGF-beta signaling regulates numerous cellular mechanisms impacting angiogenesis and cellular responses to environmental changes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (28)
Recent publications for all applications. Explore the full list and refine your search
Cells 14: PubMed40940806
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:434 PubMed39551765
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:162 PubMed38853239
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 13:e029880 PubMed38639336
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 14:49 PubMed36949528
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reviews and reports 19:491-502 PubMed36048327
2022
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 57:914-929.e7 PubMed35320732
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35328732
2022
Applications
Unspecified application
Species
Unspecified reactive species
In vivo (Athens, Greece) 35:2127-2134 PubMed34182488
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34073117
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com